Susanne Linderman

10PUBLICATIONS
84CO-AUTHORS
Procedural content generationMedical molecular engineering of nucleic acids and proteinsMolecular targetsInnate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 03, 2025
The XBB.1.5 COVID-19 vaccine elicits a durable antibody response to ancestral and XBB.1.5 SARS-CoV-2 spike proteins.

Sanjeev Kumar, Shilpi Jain, Bushra Wali

|Feb 19, 2024
XBB.1.5 monovalent booster improves antibody binding and neutralization against emerging SARS-CoV-2 Omicron variants.

Shilpi Jain, Sanjeev Kumar, Lilin Lai

|Jan 09, 2023
Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies.

Andres Chang, Jean L Koff, Lilin Lai

|Oct 05, 2022
Structural insights for neutralization of Omicron variants BA.1, BA.2, BA.4, and BA.5 by a broadly neutralizing SARS-CoV-2 antibody.

Sanjeev Kumar, Anamika Patel, Lilin Lai

|Jun 27, 2022
Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant.

Rajesh M Valanparambil, Jennifer Carlisle, Susanne L Linderman

|Apr 18, 2022
Humoral Responses Against SARS-CoV-2 and Variants of Concern After mRNA Vaccines in Patients With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia.

Andres Chang, Akil Akhtar, Susanne L Linderman

Pageof 2

Frequent Collaborators

7 joint publications

Mehul S Suthar

6 joint publications

Rajesh Valanparambil

4 joint publications

Madison L Ellis

4 joint publications

Andres Chang